Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.

× No keyword cloud information.

31 in total

Review 1. Complement receptors and the shaping of the natural antibody repertoire.

Authors: V Michael Holers
Journal: Springer Semin Immunopathol Date: 2004-12-22

Review 2. Generation of stable human autoantibody-secreting B cell hybridomas.

Authors: N Chiorazzi
Journal: Mol Biol Rep Date: 1992-05 Impact factor: 2.316

Review 3. Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.

Authors: L Hutt-Fletcher
Journal: Springer Semin Immunopathol Date: 1991

Review 4. Molecular basis for Epstein-Barr virus induced pathogenesis and disease.

Authors: C Sample; E Kieff
Journal: Springer Semin Immunopathol Date: 1991

Review 5. Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.

Authors: D T Fearon
Journal: Clin Exp Immunol Date: 1991-10 Impact factor: 4.330

6. Lymphocyte subset populations in children with polysaccharide antibody deficiency following cardiac transplantation.

Authors: A R Gennery; D Barge; G P Spickett; A J Cant
Journal: J Clin Immunol Date: 2001-01 Impact factor: 8.317

7. Tissue distribution of the C3d/EBV-receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells.

Authors: W Timens; A Boes; H Vos; S Poppema
Journal: Histochemistry Date: 1991

8. Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma.

Authors: Kazushi Tanimoto; Yoshihiro Yakushijin; Hiroshi Fujiwara; Masaki Otsuka; Koichi Ohshima; Atsuro Sugita; Akira Sakai; Takaaki Hato; Hitoshi Hasegawa; Masaki Yasukawa
Journal: Int J Hematol Date: 2009-04-11 Impact factor: 2.490

9. Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.

Authors: James M Kovacs; Jonathan P Hannan; Elan Z Eisenmesser; V Michael Holers
Journal: J Biol Chem Date: 2009-01-21 Impact factor: 5.157

10. Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia.

Authors: N Ling; T Hansel; P Richardson; B Brown
Journal: Clin Exp Immunol Date: 1991-04 Impact factor: 4.330